Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. - Wikidata - wikimedia - TriplyDB

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

http://www.wikidata.org/entity/Q45244992

about

Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia Epigenetic silencing of TIMP4 in heart failure.Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice Effects of thrombin and thrombin receptor activation on cardiac function after acute myocardial infarction Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.Anti-Parstatin Promotes Angiogenesis and Ameliorates Left Ventricular Dysfunction during Pressure Overload.Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.Cardiac tissue inhibitor of matrix metalloprotease 4 dictates cardiomyocyte contractility and differentiation of embryonic stem cells into cardiomyocytes: Road to therapy.Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation.Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus.Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice.Oxidative remodeling in pressure overload induced chronic heart failure.Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.

P2860

Q28744457-7EE36ABB-AEEA-43A7-AE65-990CDCDFB29B Q30371061-1EF4A5A4-7DEE-48B4-93D7-BCA60DB33EA0 Q33765289-F6766B33-E14C-46EC-883F-942CA8E611B0 Q34066783-32626B2F-985E-4498-A831-ADB2854DB899 Q34402844-AADD8080-7DB2-4784-AB88-A311F4C88977 Q35098436-C5042ED5-301A-4C44-9A43-AC612FC22F08 Q35231383-F241CC83-B04F-4A9D-A544-3D5A00FD2D0E Q35238627-F19E2A71-ABEB-49DD-91A9-3781F9ED4089 Q35682585-39BB629E-2AD1-4AD0-A127-83C7D37DD8E9 Q36625899-80F7D51B-97B5-4988-83CE-A03F68A95994 Q37166899-8B30AE40-E75D-4D5B-BF18-EE559C696BA8 Q37685882-41DFD82E-F0A8-4CD7-B103-AD92EB71DF0E Q37969775-14ADEFF1-4FAC-4532-802E-3069438EF556 Q40185855-15305986-755A-4D3D-89EF-9451ECE2FDCD Q41774444-E9BE061E-B907-4021-82AD-A7ACEC3992CA Q46952835-989D0C54-79AA-4A4D-ADC5-C279A0D6A9FE Q47748648-C117A051-5948-4754-BC34-9AC5492316BA Q53570599-20D42CE0-C45E-42DA-B334-3DDBF7F11A6F Q54638672-4F1D61D7-2C5B-4DBD-8B94-B2BA949B2FBE Q55053632-0E91AB2B-C77D-465E-8044-3F74B508F98A

P2860

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

http://www.wikidata.org/entity/Q45244992

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@en

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@nl

type

label

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@en

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@nl

prefLabel

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@en

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@nl

P1433

Q45244992-9F9EEC5B-ADA5-47D7-9448-ACFED237646B

P1476

Q45244992-58C85AD8-D5D8-40CC-908F-C09F1E6F6953

P2093

Q45244992-225DBFEC-BC27-492C-ADED-00BE6348F18D

Q45244992-2C31FE78-8B5E-496F-BC59-80E9666A6F07

Q45244992-4FE8C4DB-3EAF-4E25-AFAB-07E92F994871

Q45244992-6BD7BB08-D60B-4513-8449-32D4BF20A748

Q45244992-BE8C082E-9021-4944-8F12-DED68016AAB0

P2860

Q45244992-0831A572-E203-4796-8AA7-5568115D877D

Q45244992-113137DF-F5E5-47FC-BD30-1CEDAFAB9B20

Q45244992-207E37B6-B1ED-44A0-BD26-B683570B95CF

Q45244992-228FE717-91F1-49DF-AC56-9E52C1677A30

Q45244992-2B2A492E-10C9-4C72-B85E-AF38837C51E5

Q45244992-3BDD5D67-1FA1-454C-B2C1-38C3D4F347EE

Q45244992-3D61E837-7C75-4077-A94B-13FAC1410EA8

Q45244992-590E41B0-9665-4FA3-AD29-6DB8C972F87D

Q45244992-5A2025DC-87B2-46AF-A6A3-100CBC66B77C

Q45244992-6A61E7DE-28BF-4746-B12E-95F7961F55C4

P304

Q45244992-A0CF9D31-567E-4D34-9641-F0A6CDB9F0F9

P31

Q45244992-935C84E3-DD0F-48F5-8288-C8804329FCAA

P356

Q45244992-1035D189-7D84-4B99-8885-227E5772FAD7

P433

Q45244992-300C45E4-E414-419B-A9BB-1498211E6315

P478

Q45244992-3BA53FA2-F4AB-4311-A2F8-80096D17381B

P577

Q45244992-7B869DE1-91BB-4268-BCFC-ADA40EB226E3

P5875

Q45244992-0D2C563B-9665-41B7-9854-0BD488B5D915

P698

Q45244992-EC7880AE-37AD-44B8-9860-EFE2F11FDC2A

P921

Q45244992-8B04C116-EC5A-4210-95DE-986532800728

Q45244992-D6EEC307-B2D6-4946-BDEA-4069B3AFC30A

P356

AJPHEART.01146.2004

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

@en

P2093

Alexander V Ovechkin

http://www.w3.org/2001/XMLSchema#string

Brooke Henderson

http://www.w3.org/2001/XMLSchema#string

Karni S Moshal

http://www.w3.org/2001/XMLSchema#string

Neetu Tyagi

http://www.w3.org/2001/XMLSchema#string

Suresh C Tyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombin signalling and protease-activated receptors

How the protease thrombin talks to cells.

Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells.

The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats.

Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.

The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs.

Proteinases and myocardial extracellular matrix turnover.

TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts.

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.

P304

H2770-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.01146.2004

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8050010

http://www.w3.org/2001/XMLSchema#string

P698

15681708

http://www.w3.org/2001/XMLSchema#string

P921